Filgrastim biosimilar - NanogenAlternative Names: Ficocyte; Recombinant human G-CSF - Nanogen
Latest Information Update: 04 Mar 2014
At a glance
- Originator Nanogen Biopharmaceutical Co
- Class Chemoprotectants; Granulocyte colony-stimulating factors; Neuroprotectants
- Mechanism of Action Granulocyte colony stimulating factor stimulants; Haematopoiesis stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Marketed Neutropenia
Most Recent Events
- 15 Mar 2016 Biomarkers information updated
- 04 Mar 2014 Launched for Neutropenia in Vietnam (SC) prior to March 2014